This is multi-center, prospective, observational stud. This study is designed to evaluate the rate of non-serious rash in Korean bipolar I patients.
Study Type
OBSERVATIONAL
Enrollment
238
lamotrigine treatment for 12weeks
Occurrence of non-serious rash during 12 weeks of treatment with lamotrigine in patients with bipolar I in Korea
Time frame: 12 weeks
CGI-BP at Week 12 and occurrence of adverse events at Week 12
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.